Design, synthesis and biological evaluation of some new 1,3,4-thiadiazine-thiourea derivatives as potential antitumor agents against non-small cell lung cancer cells

This publication has 39 references indexed in Scilit:

• Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
  Proceedings of the National Academy of Sciences, 2012
• Synthesis, antimicrobial activity and cytotoxicity of novel oxadiazole derivatives
  Journal of Enzyme Inhibition and Medicinal Chemistry, 2011
• Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents
  European Journal of Medicinal Chemistry, 2010
• Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
  Angiogenesis, 2009
• Combining Targeted Therapies and Drugs with Multiple Targets in the Treatment of NSCLC
  The Oncologist, 2006
• Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
  Biochemical and Biophysical Research Communications, 2005
• New method for the analysis of cell cycle–specific apoptosis
  Cytometry Part A, 2004
• Prognostic impact of matrix metalloproteinase‐9 in operable non‐small cell lung cancer
  International Journal of Cancer, 2002
• Mutations of the BRAF gene in human cancer
  Nature, 2002
• Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor
  Journal of Molecular Biology, 2002